Table 3.
Propensity Score Matched Cohort (1:1) of Sarcoidosis Hospitalizations Between Blacks and Whites
| Variable Name | Blacks (n=155 665) | Whites (n=155 665) | P Value |
|---|---|---|---|
| Age, y | 54.2±12.3 | 54.3±12.6 | 0.11 |
| Sex, % | |||
| Female | 75.8 | 75.8 | 0.71 |
| Male | 24.2 | 24.2 | |
| Comorbidities, % | |||
| Diabetes mellitus | 24.2 | 24.2 | 0.71 |
| Hypertension | 52.5 | 52.8 | 0.09 |
| Liver disease | 3.1 | 3.2 | 0.32 |
| Fluid and electrolyte disorder | 22.1 | 22.1 | 0.88 |
| Neurological disorder | 5.2 | 5.4 | 0.17 |
| Coagulopathy | 3.0 | 2.8 | 0.40 |
| Chronic pulmonary disease | 27.6 | 27.5 | 0.33 |
| Congestive heart failure | 6.6 | 7.0 | 0.22 |
| Anemia | 14.8 | 15 | 0.06 |
| Solid tumor with metastasis | 1.4 | 1.3 | 0.70 |
| Metastatic cancer | 1.6 | 1.7 | 0.15 |
| Pulmonary circulation disorders | 3.8 | 3.9 | 0.16 |
| Renal failure | 9.3 | 9.4 | 0.28 |
| In‐hospital outcomes | |||
| In‐hospital mortality | 1.8 | 1.5 | <0.001 |
| Length of stay, median (IQR)a | 4 (2–6) | 3 (2–6) | <0.001 |
| Cardiac arrest, % | 0.5 | 0.3 | <0.001 |
| In‐hospital outcomes, OR (95% CI) | |||
| In‐hospital mortality | 1.20 (1.14–1.27) | <0.001 | |
| Cardiac arrest | 1.67 (1.49–1.87) | <0.001 | |
Data are presented as mean±SD or number (percentage) or percentage. CI indicates confidence interval; OR, odds ratio.
a
Interquartile range (IQR) is from Q1 to Q3.